🎉 M&A multiples are live!
Check it out!

Mindray Valuation Multiples

Discover revenue and EBITDA valuation multiples for Mindray and similar public comparables like Myomo, InfuSystem, and SmartVest.

Mindray Overview

About Mindray

Shenzhen Mindray Bio-Medical Electronics Co Ltd is a developer, manufacturer, and supplier of medical devices. The company is focused on the medical industry in the fields of Patient Monitoring & Life Support, InVitro Diagnostics, and Medical Imaging.


Founded

1999

HQ

China
Employees

n/a

Website

mindray.com

Financials

LTM Revenue $5.4B

LTM EBITDA $2.0B

EV

$33.9B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Mindray Financials

Mindray has a last 12-month revenue (LTM) of $5.4B and a last 12-month EBITDA of $2.0B.

In the most recent fiscal year, Mindray achieved revenue of $5.1B and an EBITDA of $2.0B.

Mindray expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Mindray valuation multiples based on analyst estimates

Mindray P&L

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $5.4B XXX $5.1B XXX XXX XXX
Gross Profit $3.4B XXX $3.2B XXX XXX XXX
Gross Margin 63% XXX 63% XXX XXX XXX
EBITDA $2.0B XXX $2.0B XXX XXX XXX
EBITDA Margin 37% XXX 39% XXX XXX XXX
EBIT $1.9B XXX $1.8B XXX XXX XXX
EBIT Margin 35% XXX 36% XXX XXX XXX
Net Profit $1.7B XXX $1.6B XXX XXX XXX
Net Margin 32% XXX 32% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Mindray Stock Performance

As of July 17, 2025, Mindray's stock price is CNY 215 (or $30).

Mindray has current market cap of CNY 260B (or $36.3B), and EV of CNY 243B (or $33.9B).

See Mindray trading valuation data

Mindray Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$33.9B $36.3B XXX XXX XXX XXX $1.40

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Mindray Valuation Multiples

As of July 17, 2025, Mindray has market cap of $36.3B and EV of $33.9B.

Mindray's trades at 6.6x EV/Revenue multiple, and 16.8x EV/EBITDA.

Equity research analysts estimate Mindray's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Mindray has a P/E ratio of 21.4x.

See valuation multiples for Mindray and 12K+ public comps

Mindray Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $36.3B XXX $36.3B XXX XXX XXX
EV (current) $33.9B XXX $33.9B XXX XXX XXX
EV/Revenue 6.3x XXX 6.6x XXX XXX XXX
EV/EBITDA 17.1x XXX 16.8x XXX XXX XXX
EV/EBIT 18.2x XXX 18.6x XXX XXX XXX
EV/Gross Profit 10.0x XXX n/a XXX XXX XXX
P/E 21.4x XXX 22.3x XXX XXX XXX
EV/FCF 23.2x XXX 23.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Mindray Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Mindray Margins & Growth Rates

Mindray's last 12 month revenue growth is 11%

Mindray's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Mindray's rule of 40 is 51% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Mindray's rule of X is 65% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Mindray and other 12K+ public comps

Mindray Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 11% XXX 11% XXX XXX XXX
EBITDA Margin 37% XXX 39% XXX XXX XXX
EBITDA Growth 12% XXX 3% XXX XXX XXX
Rule of 40 51% XXX 51% XXX XXX XXX
Bessemer Rule of X XXX XXX 65% XXX XXX XXX
Revenue per Employee XXX XXX n/a XXX XXX XXX
Opex per Employee XXX XXX n/a XXX XXX XXX
S&M Expenses to Revenue XXX XXX 3% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 10% XXX XXX XXX
Opex to Revenue XXX XXX 28% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Mindray Public Comps

See public comps and valuation multiples for Medical Devices and Medical Supplies comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Mindray M&A and Investment Activity

Mindray acquired  XXX companies to date.

Last acquisition by Mindray was  XXXXXXXX, XXXXX XXXXX XXXXXX . Mindray acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Mindray

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About Mindray

When was Mindray founded? Mindray was founded in 1999.
Where is Mindray headquartered? Mindray is headquartered in China.
Is Mindray publicy listed? Yes, Mindray is a public company listed on SHE.
What is the stock symbol of Mindray? Mindray trades under 300760 ticker.
When did Mindray go public? Mindray went public in 2018.
Who are competitors of Mindray? Similar companies to Mindray include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Mindray? Mindray's current market cap is $36.3B
What is the current revenue of Mindray? Mindray's last 12 months revenue is $5.4B.
What is the current revenue growth of Mindray? Mindray revenue growth (NTM/LTM) is 11%.
What is the current EV/Revenue multiple of Mindray? Current revenue multiple of Mindray is 6.3x.
Is Mindray profitable? Yes, Mindray is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Mindray? Mindray's last 12 months EBITDA is $2.0B.
What is Mindray's EBITDA margin? Mindray's last 12 months EBITDA margin is 37%.
What is the current EV/EBITDA multiple of Mindray? Current EBITDA multiple of Mindray is 17.1x.
What is the current FCF of Mindray? Mindray's last 12 months FCF is $1.5B.
What is Mindray's FCF margin? Mindray's last 12 months FCF margin is 27%.
What is the current EV/FCF multiple of Mindray? Current FCF multiple of Mindray is 23.2x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.